Literature DB >> 20581676

The effects of statins on skeletal muscle strength and exercise performance.

Guru M Krishnan1, Paul D Thompson.   

Abstract

PURPOSE OF REVIEW: HMG-CoA reductase inhibitors or statins are associated with a variety of muscle side-effects but little is known about the effect of statins on skeletal muscle strength and exercise performance. We performed a literature search to examine these issues. RECENT
FINDINGS: We identified six studies examining the effect of statins on muscle strength and nine studies examining their effect on exercise tolerance. In general, studies examining both issues were small and used crude measures of strength and exercise performance.
SUMMARY: There is insufficient data to determine if statins affect muscle strength and exercise performance. There is suggestive evidence that these drugs may reduce muscle strength in older patients and alter energy metabolism during aerobic exercise, both possibilities require further study.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20581676     DOI: 10.1097/MOL.0b013e32833c1edf

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  20 in total

1.  Statins and Exercise Training Response in Heart Failure Patients: Insights From HF-ACTION.

Authors:  Jacob P Kelly; Allison Dunning; Phillip J Schulte; Mona Fiuzat; Eric S Leifer; Jerome L Fleg; Lawton S Cooper; Steven J Keteyian; Dalane W Kitzman; Ileana L Pina; William E Kraus; David J Whellan; Christopher M O'Connor; Robert J Mentz
Journal:  JACC Heart Fail       Date:  2016-07-06       Impact factor: 12.035

2.  The effect of statins on skeletal muscle function: the STOMP trial.

Authors:  John A Farmer
Journal:  Curr Atheroscler Rep       Date:  2013-08       Impact factor: 5.113

Review 3.  The effects of statin medications on aerobic exercise capacity and training adaptations.

Authors:  Zsolt Murlasits; Zsolt Radák
Journal:  Sports Med       Date:  2014-11       Impact factor: 11.136

4.  Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.

Authors:  Makoto Kinoshita; Koutaro Yokote; Hidenori Arai; Mami Iida; Yasushi Ishigaki; Shun Ishibashi; Seiji Umemoto; Genshi Egusa; Hirotoshi Ohmura; Tomonori Okamura; Shinji Kihara; Shinji Koba; Isao Saito; Tetsuo Shoji; Hiroyuki Daida; Kazuhisa Tsukamoto; Juno Deguchi; Seitaro Dohi; Kazushige Dobashi; Hirotoshi Hamaguchi; Masumi Hara; Takafumi Hiro; Sadatoshi Biro; Yoshio Fujioka; Chizuko Maruyama; Yoshihiro Miyamoto; Yoshitaka Murakami; Masayuki Yokode; Hiroshi Yoshida; Hiromi Rakugi; Akihiko Wakatsuki; Shizuya Yamashita
Journal:  J Atheroscler Thromb       Date:  2018-08-22       Impact factor: 4.928

5.  Multimorbidity, polypharmacy and primary prevention in community-dwelling adults in Quebec: a cross-sectional study.

Authors:  Tu N Nguyen; Patrice Ngangue; Jeannie Haggerty; Tarek Bouhali; Martin Fortin
Journal:  Fam Pract       Date:  2019-11-18       Impact factor: 2.267

6.  Skeletal muscle ultrastructure and function in statin-tolerant individuals.

Authors:  Jason L Rengo; Damien M Callahan; Patrick D Savage; Philip A Ades; Michael J Toth
Journal:  Muscle Nerve       Date:  2015-12-09       Impact factor: 3.217

Review 7.  Individualized risk for statin-induced myopathy: current knowledge, emerging challenges and potential solutions.

Authors:  QiPing Feng; Russell A Wilke; Tesfaye M Baye
Journal:  Pharmacogenomics       Date:  2012-04       Impact factor: 2.533

8.  Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial.

Authors:  Jean S Kutner; Patrick J Blatchford; Donald H Taylor; Christine S Ritchie; Janet H Bull; Diane L Fairclough; Laura C Hanson; Thomas W LeBlanc; Greg P Samsa; Steven Wolf; Noreen M Aziz; David C Currow; Betty Ferrell; Nina Wagner-Johnston; S Yousuf Zafar; James F Cleary; Sandesh Dev; Patricia S Goode; Arif H Kamal; Cordt Kassner; Elizabeth A Kvale; Janelle G McCallum; Adeboye B Ogunseitan; Steven Z Pantilat; Russell K Portenoy; Maryjo Prince-Paul; Jeff A Sloan; Keith M Swetz; Charles F Von Gunten; Amy P Abernethy
Journal:  JAMA Intern Med       Date:  2015-05       Impact factor: 21.873

Review 9.  The Interaction Between Statins and Exercise: Mechanisms and Strategies to Counter the Musculoskeletal Side Effects of This Combination Therapy.

Authors:  Richard E Deichmann; Carl J Lavie; Timothy Asher; James J DiNicolantonio; James H O'Keefe; Paul D Thompson
Journal:  Ochsner J       Date:  2015

Review 10.  Effect of statins on skeletal muscle: exercise, myopathy, and muscle outcomes.

Authors:  Beth A Parker; Paul D Thompson
Journal:  Exerc Sport Sci Rev       Date:  2012-10       Impact factor: 6.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.